Related Info Links
More by Authors Links
News and Announcements
EDITORIAL
Epilepsy advances and neuromodulation
Show Less
1 Sunstone Health Precision Therapeutics, Boston, Massachusetts,
United States of America
Advanced Neurology, 026260030 https://doi.org/10.36922/AN026260030
Received: 26 June 2026 | Accepted: 20 July 2026 | Published online: 10 August 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Conflict of interest
Paul R. Carney serves as an Editorial Board Member of this journal. The author declares that he has no competing interests.
References
- Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. doi: 10.1111/j.1528-1167.2009.02397.x
- Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908. doi: 10.1111/j.1528-1167.2010.02536.x
- Morrell MJ. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77(13):1295-1304. doi: 10.1212/WNL.0b013e3182302056
- Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020;95(9). doi: 10.1212/wnl.0000000000010154
- Touma L, Dansereau B, Chan AY, et al. Neurostimulation in people with drug-resistant epilepsy: systematic review and meta-analysis from the ILAE Surgical Therapies Commission. Epilepsia. 2022;63(6):1314-1329. doi: 10.1111/epi.17243
